SM
SANA icon

SB Management’s Sana Biotechnology SANA Stock Holding History

SB Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,209,004
Closed -$34.2M – 23
2021
Q4 		$34.2M Hold
2,209,004
– – 3.38% 8
2021
Q3 		$49.7M Sell
2,209,004
-416,149
-16% -$8.74M 5.1% 5
2021
Q2 		$51.6M Hold
2,625,153
– – 0.61% 10
2021
Q1 		$87.9M Buy
+2,625,153
New +$85.5M 0.57% 11

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

SB Management's SANA Position: Q1 2022 in Review

SB Management sold out of Sana Biotechnology (SANA) in Q1 2022, closing a stake of 2,209,004 shares — an estimated $34.2M sold.

SB Management first reported a position in SANA in Q1 2021 and held it in 4 quarters. The position peaked at $87.9M in Q1 2021. 117 funds tracked by Wall St. Rank hold SANA as of Q1 2022.

  • SB Management reported no remaining Sana Biotechnology position as of Q1 2022 after selling out during the quarter.
  • SB Management sold 2,209,004 Sana Biotechnology shares in Q1 2022, an estimated $34.2M.
  • SB Management first reported a position in Sana Biotechnology in Q1 2021 and held it in 4 quarters.
  • SB Management's Sana Biotechnology position peaked at $87.9M in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2022.

Based on SB Management's 13F filing for Q1 2022, filed 16 May 2022.